Patients suspended unreliable drugs trial on 60 Ukrainian people

For more than a year already international and patient organizations tried to get precise information from Mili Healthcare pharmaceutical company about their new biosimilar product Peginterferon for HCV treatment. This drug was registered […]

Meeting with ViiV/GSK

During the meeting of UCAB members and state bodies’ representatives for the first time an agreement on the inclusion of patients into the group under the Ministry of Health of Ukraine (MoH) responsible for the list […]